These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25523687)

  • 1. Re: Women's expectations and experiences of hormone treatment for sexual dysfunction.
    Seftel AD
    J Urol; 2015 Jan; 193(1):250. PubMed ID: 25523687
    [No Abstract]   [Full Text] [Related]  

  • 2. Women's expectations and experiences of hormone treatment for sexual dysfunction.
    Fooladi E; Bell RJ; Whittaker AM; Davis SR
    Climacteric; 2014 Dec; 17(6):674-81. PubMed ID: 24884596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo response in the treatment of women's sexual dysfunctions: a review and commentary.
    Bradford A; Meston CM
    J Sex Marital Ther; 2009; 35(3):164-81. PubMed ID: 19360517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [US approval of flibanserin. Germany should make no hype over the "lust pill" ].
    Kossow S; Müller T
    MMW Fortschr Med; 2015 Oct; 157(17):8. PubMed ID: 26759857
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicalization of women's sexual problems: a different story?
    Graham CA
    J Sex Marital Ther; 2007; 33(5):443-7. PubMed ID: 17674225
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women".
    Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():177-8. PubMed ID: 18783531
    [No Abstract]   [Full Text] [Related]  

  • 7. A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD).
    Orri M; Abraham L; Giraldi A
    J Sex Med; 2013 Oct; 10(10):2484-96. PubMed ID: 23347610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2012 Congress of International Society for the Study of Women's Sexual Health (ISSWSH), 19-22 February, Jerusalem, Israel].
    Buisson O; Buvat J
    Gynecol Obstet Fertil; 2012 Jun; 40(6):373-5. PubMed ID: 22658402
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlates of placebo response in the treatment of sexual dysfunction in women: a preliminary report.
    Bradford A; Meston C
    J Sex Med; 2007 Sep; 4(5):1345-51. PubMed ID: 17666035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and management of women's sexual dysfunctions: problematic desire and arousal.
    Basson R; Brotto LA; Laan E; Redmond G; Utian WH
    J Sex Med; 2005 May; 2(3):291-300. PubMed ID: 16422860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options for postmenopausal female sexual dysfunction.
    Al-Azzawi F; Bitzer J; Brandenburg U; Castelo-Branco C; Graziottin A; Kenemans P; Lachowsky M; Mimoun S; Nappi RE; Palacios S; Schwenkhagen A; Studd J; Wylie K; Zahradnik HP
    Climacteric; 2010 Apr; 13(2):103-20. PubMed ID: 19958161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female sexual satisfaction and pharmaceutical intervention: a critical review of the drug intervention studies in female sexual dysfunction.
    Nijland E; Davis S; Laan E; Schultz WW
    J Sex Med; 2006 Sep; 3(5):763-777. PubMed ID: 16942521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
    Gregersen N; Jensen PT; Giraldi AE
    Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating components of sexual well-being in women: are sexual satisfaction and sexual distress independent constructs?
    Stephenson KR; Meston CM
    J Sex Med; 2010 Jul; 7(7):2458-68. PubMed ID: 20456625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual health consequences of premature ovarian failure.
    Davis SR
    Menopause; 2008; 15(1):5-6. PubMed ID: 17917614
    [No Abstract]   [Full Text] [Related]  

  • 16. Viagra improves sexual function in women taking antidepressants.
    Harv Womens Health Watch; 2008 Oct; 16(2):7. PubMed ID: 19051427
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress in pharmacotherapy of female sexual dysfunction].
    Rao T; Zhang XB
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1023-7. PubMed ID: 18077918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Needs assessment.
    J Sex Med; 2008 Sep; 5 Suppl 4():179. PubMed ID: 18783532
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in pharmacotherapy for treating female sexual dysfunction.
    Nappi RE; Cucinella L
    Expert Opin Pharmacother; 2015 Apr; 16(6):875-87. PubMed ID: 25732267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standards in Studies of Psychotherapy and Pharmacotherapy Interventions for HSDD.
    Clayton AH; Pyke RE
    J Sex Marital Ther; 2017 Apr; 43(3):206-209. PubMed ID: 27649260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.